Found 5 matching trials
Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma
PHASE2The purpose of this study is to determine the feasibility and tolerability ...
Location
Kinghorn Cancer Centre, St. Vincent's Hospital
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
PHASE1This is a Phase 1/2, multi-center, open-label basket study designed to eval...
Location
UCLA Medical Center
(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
PHASE2Neoadjuvant/adjuvant IDE196 (darovasertib) in patients with primary uveal m...
Status
Active Not Recruiting
Location
HonorHealth Research Institute
IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma
PHASE2This is a Phase 2/3, multi-arm, multi-stage, open-label study of human leuk...
Status
Active Not Recruiting
Neoadjuvant Darovasertib in Primary Uveal Melanoma
PHASE3This is a Phase 3, randomized, multi-center, open-label study of neoadjuvan...
Location
Mayo Clinic Scottsdale - PPDS